Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Dermata Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DRMA.
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Acurx Pharmaceuticals (NASDAQ:ACXP), Can Fite Biofarma (AMEX:CANF) and Portage Biotech (NASDAQ:PRTG).
Dermata Therapeutics has a consensus price target of $6.00.
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $1.21 last updated March 20, 2025 at 9:08 AM EDT.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.